Gastric cancer immunotherapy. THERRES | Institutul Clinic Fundeni
Dr. Ku on Immunotherapy for Gastric and Esophageal Cancer
Recent research offers previously unavailable opportunities to make substantial progress in GC therapy. Targeted therapies have revolutionized GC treatment, but benefit remain limited, with only a few months increase in overall survival.
The current challenge is the proper stratification gastric cancer immunotherapy patients, in order to implement an adequate therapy, and to identify primary and acquired resistance to treatment. As such, this project focuses on the valorification of the research infrastructure of the partners.
Results could have a major importance in the field of gastric cancer therapies, contributing to an improved quality of life and overall survival of GC patients, by translating scientific results in new opportunities of personalized treatment.
Main objective THERRES is an extremely ambitious and innovative project, focusing on the association of immunotherapy with molecular oriented drugs in gastric cancer, as gastric cancer immunotherapy modern method of treatment.
- Nutriție pentru tratarea paraziților
- Medicamente cu cernagilis fără prescripție medicală
- Imunoterapia în cancer: mecanismele imunologice şi rolul lor în terapie Gastric cancer immunotherapy Conținutul La comanda in aproximativ 4 saptamani Edited by worldrenowned practising oncologists and written by key opinion leaders, this book contains authoritative and gastric cancer immunotherapy information on cancer detection, diagnosis and treatment alongside topics such as survivorship, special populations and palliative care.
- Aplicație de enterobioză
- Autoinvazie enterobiaza
The project aims to implement a new classification system to distinguish between gastric cancer subtypes and to characterize regulatory molecules of immune function immune checkpoints Specific objectives: Objective 1: Identification of biomarkers and potential therapy targets gastric cancer immunotherapy GC subtypes defined on the basis of recent genomic classifications Objective 2: Identifying response and resistance biomarkers to standard anti-HER2, anti-MET and anti-VEGF therapy in GC Gastric cancer immunotherapy 3: Characterizing vascular stroma particularities in GC, including the role on immune checkpoints in GC subtypes.
As a key result, the project will generate instruments to guide treatment decisions and help in the management of GC patients through a personalized approach. The result of the present project will contribute to improving the performance, quality and international visibility of Romanian scientific results in the oncology field.
Institutul nostru are o veche traditie in patologia dificila cardio-vasculara, hepatica, renala, digestiva, hematologica, etc. La inceput de mileniu III specialistii din Institutul Clinic Fundeni sunt pregatiti sa abordeze asemenea probleme nu numai prin prisma practicii de zi cu zi, ci si sub aspectul cercetarii fundamentale.
